Back to News

Roche Selects ³Ô¹Ï±¬ÁÏ Development Cloud Applications

Leading pharmaceutical company selects ³Ô¹Ï±¬ÁÏ Vault applications
across clinical, regulatory, and quality

PLEASANTON, CA ¡ª Oct. 12, 2020 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced that Roche (SWX: ROG) has selected ³Ô¹Ï±¬ÁÏ Development Cloud applications globally to streamline clinical, regulatory, and quality processes. The company is switching to unified applications in Vault Clinical, Vault RIM, and Vault Quality suites to increase efficiency, enhance data quality, and drive compliance throughout the product lifecycle.

¡°Speeding drug development and product supply are strategic priorities for innovative life sciences companies like Roche,¡± said Rik Van Mol, vice president of ³Ô¹Ï±¬ÁÏ Development Cloud. ¡°³Ô¹Ï±¬ÁÏ Development Cloud breaks down system and process silos so life sciences companies can more quickly bring innovative treatments to patients.¡±

Roche is standardizing on clinical applications Vault eTMF and Vault CTMS, regulatory applications Vault Submissions, Vault Registrations, and Vault Submissions Archive, and quality applications Vault QMS and Vault QualityDocs.

Learn more about ³Ô¹Ï±¬ÁÏ Vault Development Cloud at the upcoming ³Ô¹Ï±¬ÁÏ R&D and Quality Summit, October 13-14, 2020. The online event is open to life sciences industry professionals. Register and stay up to date on program details at veeva.com/Summit.

Additional Information
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ Systems Inc. is a leader in cloud solutions¡ªincluding data, software, and services¡ªfor the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 900 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. The company is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.

###

Contact:

³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com

Deivis Mercado
³Ô¹Ï±¬ÁÏ Systems
925-226-8821
deivis.mercado@veeva.com